ArticleMolecular oncology2016

Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels.

Christa Haldrup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.